Overview of Glucose Dependent Insulinotropic Polypeptide Receptor Expressing

Ambiguity regarding the role of glucose-dependent insulinotropic polypeptide (GIP) in obesity arises from conflicting reports asserting that both GIP receptor (GIPR) agonism and antagonism are effective strategies for inhibiting weight gain. To enable identification and manipulation of Gipr-expressi …

The related gut hormone glucose-dependent insulinotropic polypeptide (GIP) also controls blood glucose , but its role in food intake is debated. Researchers at the Institute of Metabolic Science in Cambridge, UK identified neurons expressing the GIP receptor in food intake control centers of mouse and human brain.
Key Details About Glucose Dependent Insulinotropic Polypeptide Receptor Expressing

Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression.
Summary The next generation of obesity medicines harness the activity of the glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 receptors (GIPR and GLP-1R), but their mechanism of action remains unclear. Here, we report that the GIPR is enriched in oligodendrocytes and GIPR signaling bidirectionally regulates ...

Gastric inhibitory polypeptide receptor
The gastric inhibitory polypeptide receptor (GIP-R), also known as the glucose-dependent insulinotropic polypeptide receptor , is a protein that in humans is encoded by the GIPR gene. [5][6] GIP-R is a member of the class B family of G protein coupled receptors . [7] GIP-R is found on beta-cells in the pancreas [8][9] where it serves as the receptor for the hormone Gastric inhibitory polypeptide ...
The development of single-molecule co-agonists for the glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) is considered a ...

New insights into the regulation of GIPR signalling
Two recent studies have unravelled novel modes of glucose-dependent insulinotropic polypeptide receptor (GIPR) signalling regulation. Kizilkaya et al. characterized the effect of changes in β ...
Glucose-dependent insulinotropic polypeptide (GIP) was the first incretin identified and plays an essential role in the maintenance of glucose tolerance in healthy humans. Until recently GIP had not been developed as a therapeutic and thus has been ...

Key Details About Glucose Dependent Insulinotropic Polypeptide Receptor Expressing
Abstract Glucose-dependent insulinotropic polypeptide (GIP) is a 42-amino acid hormone that is synthesized and released from upper intestinal enteroendocrine K cells in response to the ingestion of glucose or fat. The structure of GIP places it in the secretin/vasoactive intestinal polypeptide family of gastrointestinal regulatory peptides.






Under normal conditions, glucose-dependent insulinotropic polypeptide (GIP) plays a major role in nutrient deposition and storage, and is overexpressed in obese individuals, which may exacerbate insulin resistance manifested by many patients with type 2 diabetes mellitus.